. In this investigation, we explored the possibility that collaboration might exist between these cells. TIL-T were isolated from 39 lymph nodes of patients with NHL. In most of the cases, few of them (less than 10%) possessed surface activation receptors CD25 or OKT9. In 80% of the cases, they proliferated in response to recombinant interleukin-2 (rlL-2). but the degree of proliferation was often low as compared with control populations. The influence of irradiated autologous malignant cells on the TIL-T proliferation in response to rlL-2 (40 U/mL) was also investigated: in 38% of the cases, this proliferation was not modified (group 0). and in 41 % it was higher (group +) and in 21 % it was lower (group -1. The mechanism of this immune ON-HODGKIN'S LYMPHOMAS (NHL) constitute N a heterogenous group of lymphoid tumors, the majority of which are of the B-cell type. Lymph nodes are invaded by the malignant monoclonal B cells arrested at different stages of differentiation' together with other cells, which are probably normal, that make up the tumor microenvironment. Among them are T lymphocytes, which are present in much variable proportions from one patient to another. Their role and significance in the pathogenesis of the disease remain unknown. It is obvious that there are often too many of them to be considered as simple residual elements from the normal lymph node structure. They possibly may represent a nonspecific accumulation of blood-borne lymphocytes sequestered in the tumor secondarily to an altered pattern of leukocyte extravasation2 One might also postulate that they proliferate in situ in contact with the malignant clone. It is now well-established that T lymphocytes are capable of proliferating under the influence of autologous stimuli either in contact with other normal lymphoid cell^^.^ (ie, the autologous mixed lymphocyte reaction [AMLR]), or in contact with tumor cells2" (ie, the mixed lymphocyte tumor culture [MLTC]). Many investigators referred to positive MLTC between peripheral blood T lymphocytes and malignant cells,'-'' but the demonstration of stimulation within the tumor is rare because of the difficulty in isolating tumor-infiltrating T lymphocytes (TIL-T) in solid tumors.2.'2 The identification with monoclonal antibodies (MoAbs) of activated TIL-T on histologic slides is often the only element in favor of their reactive ~h a r a c t e r .~. '~. '~ Nevertheless, many studies support their implication in the tumoral process: T lymphocytes isolated from lymph nodes with B-cell type N H L are capable of inhibiting immunoglobulin (Ig) secretion by the malignant clone," secreting lymphokines to which B cells are potentially sensitive (references 18 through 20 and personal observations, T. Bonnefoix, 1988), and developing cytotoxic activities toward malignant cells.2' They also appear to be responsible for granuloma formation in Hodgkin's disease (personal observations, M.P. Piccinni, 1989). Our objective is to explore the possible existence of an immunologic response within lymph nodes invaded by B-cell-derived NHL. We first looked for evidence of activation features in isolated TIL-T by studying the presence of interleukin-2 (IL-2)22 and t r a n~f e r r i n~~ membrane receptors as well as for the existence of a response to recombinant IL-2 (rIL-2). In the absence of any other stimulation and a t low concentrations, rIL-2 induces the proliferation of activated T lymphocytes only.24 Secondly, we explored direct functional interactions between the tumor and its microenvironment by analyzing the influence of the B-cell clone on the response to rIL-2 of T lymphocytes isolated from the same lymph node.
Tumor-infiltrating T lymphocytes (TIL-T) are always present in B-cell-derived non-Hodgkin's lymphoma (NHL)
. In this investigation, we explored the possibility that collaboration might exist between these cells. TIL-T were isolated from 39 lymph nodes of patients with NHL. In most of the cases, few of them (less than 10%) possessed surface activation receptors CD25 or OKT9. In 80% of the cases, they proliferated in response to recombinant interleukin-2 (rlL-2). but the degree of proliferation was often low as compared with control populations. The influence of irradiated autologous malignant cells on the TIL-T proliferation in response to rlL-2 (40 U/mL) was also investigated: in 38% of the cases, this proliferation was not modified (group 0). and in 41 % it was higher (group +) and in 21 % it was lower (group -1. The mechanism of this immune
ON-HODGKIN'S LYMPHOMAS (NHL) constitute
N a heterogenous group of lymphoid tumors, the majority of which are of the B-cell type. Lymph nodes are invaded by the malignant monoclonal B cells arrested at different stages of differentiation' together with other cells, which are probably normal, that make up the tumor microenvironment. Among them are T lymphocytes, which are present in much variable proportions from one patient to another. Their role and significance in the pathogenesis of the disease remain unknown. It is obvious that there are often too many of them to be considered as simple residual elements from the normal lymph node structure. They possibly may represent a nonspecific accumulation of blood-borne lymphocytes sequestered in the tumor secondarily to an altered pattern of leukocyte extravasation2 One might also postulate that they proliferate in situ in contact with the malignant clone. It is now well-established that T lymphocytes are capable of proliferating under the influence of autologous stimuli either in contact with other normal lymphoid cell^^.^ (ie, the autologous mixed lymphocyte reaction [AMLR] ), or in contact with tumor cells2" (ie, the mixed lymphocyte tumor culture [MLTC] ). Many investigators referred to positive MLTC between peripheral blood T lymphocytes and malignant cells,'-'' but the demonstration of stimulation within the tumor is rare because of the difficulty in isolating tumor-infiltrating T lymphocytes (TIL-T) in solid tumors.2.'2 The identification with monoclonal antibodies (MoAbs) of activated TIL-T on histologic slides is often the only element in favor of their reactive ~h a r a c t e r .~. '~. '~ Nevertheless, many studies support their implication in the tumoral process: T lymphocytes isolated from lymph nodes with B-cell type N H L are capable of inhibiting immunoglobulin (Ig) secretion by the malignant clone," secreting lymphokines to which B cells are potentially sensitive (references 18 through 20 and personal observations, T. Bonnefoix, 1988), and developing cytotoxic activities toward malignant cells.2' They also appear to be responsible for granuloma formation in Hodgkin's disease (personal observations, M.P. Piccinni, 1989). Our objective is to explore the possible existence of an immunologic response within lymph nodes invaded by B-cell-derived NHL. We first looked for evidence of activation features in isolated TIL-T by studying the presence of interleukin-2 (IL-2)22 and t r a n~f e r r i n~~ membrane receptors as well as for the existence of a response to recombinant IL-2 (rIL-2). In the absence of any other stimulation and a t low concentrations, rIL-2 induces the proliferation of activated T lymphocytes only.24 Secondly, we explored direct functional interactions between the tumor and its microenvironment by analyzing the influence of the B-cell clone on the response to rIL-2 of T lymphocytes isolated from the same lymph node.
MATERIALS AND METHODS

Lymphoid Tissue
Biopsy specimens were analyzed from different patients with B-cell NHL. The only criteria for selection was the recovery of a sufficient number of lymphocytes after extraction. Thirty-eight lymph nodes and 1 spleen were analyzed. Clinical status is given in Table 1 . Sex ratio was 1.8 men for 1 woman and the mean age 61 years (24 to 89 years). Twenty-five patients were studied at the time of diagnosis and 14 after relapse (10 were studied at least 6 months after treatment cessation and four were being treated at the time of biopsy). Lymph nodes 5a 5b and 17a 17b each represent two biopsy samples from the same patient, one at the time of diagnosis and one at the first relapse. the latter, NHL are classified with regard to the morphologic than 18 pm). Nuclear cytoplasmic ratio and basophilia may be high features observed under optic microscope. Three groups having a prognostic value are identified essentially from a statistical analysis. In class 1, cells are small lymphocytes (less than 18 pm) with a low cytoplasmic basophilia and less than 1% mitoses. These NHL are related to a favorable prognosis: their evolution remains locoregional for a long time, up to several years. In class 2, cells have a high nuclear cytoplasmic ratio, a high basophilic cytoplasm, and divide frequently (greater than 1% mitoses). Lymphoid cell size is also relatively small (less than 18 pm). These NHL have a poor prognosis with frequent evolution toward acute lymphoblastic leukemia. In class 3, more than 20% of the cells are large cells (greater or low. These NHL also have a poor prognosis, and behave like solid tumors with early metastases. The immunologic features of the clone are also given in Table 1 . Blood samples from 10 healthy donors and lymph nodes from five cases of benign hyperplasia were included as controls.
T-and B-Cell Separation Procedures
Whole lymph nodes were received in our laboratory immediately after extraction. They were gently dissociated with a scalpel in RPMI 1640 medium (Boehringer Mannheim, Germany) and washed twice. The suspension was depleted of macrophages by adherence on Sephadex G10 (Pharmacia, Sweden). T and B lymphocytes were then separated by rosetting with aminoethylthiouroniumbromidhydrobromide (AET)-sensitized sheep red blood cells (RBCs). Cells were incubated at 4OC overnight, then separated by centrifugation on Ficoll hypaque density gradients. B lymphocytes were removed from the Ficoll medium interface and washed twice. The degree of purity, evaluated by the presence of surface Igs, always exceeded 90%. T lymphocytes were recovered in the pellet. If the proportion of the rosette-forming cells was inferior to 90%, a second or third centrifugation on Ficoll was performed. RBCs were eliminated by lysis with distilled water. The purity of the suspension, evaluated by a positive reaction with anti-CD3 MoAb, ranged from 90% to 98%. For peripheral blood (collected into sterile heparinized tubes) and spleen samples, a preliminary centrifugation on Ficoll hypaque was made to recover mononuclear cells.
Immunostaining
The antibodies used were fluoresceine isothiocyanate (FITC)-conjugated goat F(ab'), fragments of anti-human heavy and light chain Ig antibodies (Kallestadt, Minnesota), and nonconjugated mice MoAbs: CD3, OKT9 (Ortho Diagnostic Systems, Australia); CD19, CD20, CD24 (Coulter Clone, France); CD4 (Dako Patts, Denmark); CD8, CD25 (Immunotech, France); and CD5, CDlO (a kind gift from A. Bernard, Nice, France). With the MoAbs, an FITC-conjugated goat anti-mouse Ig antiserum (Immunotech) was used as a second-step reagent. Fluorescence analysis was performed on a cytofluorimeter (FACScan; Becton Dickinson, Mountain View, CA).
Proliferation Tests
Tests were performed in 96-well flat-bottomed plates (Falcon, Becton Dickinson). On day 1, lo5 lymphocytes were seeded alone or with lo5 irradiated B cells (3,000 rads). The final volume was 0.2 mL RPMI 1640 (Boehringer) supplemented with 2 mmol/L glutamine, 25 mmol/L Hepes, 10% fetal calf serum (Flow Laboratories, England), 100 IU penicillin, and 100 pg/mL streptomycin (Flow Laboratories). IL-2 (Boehringer) was added at a concentration of 40 U/mL. All assays were performed in triplicate. On day 6, 'Hthymidine (1 pCi/well, CEA Commissariat-1'Energie Atomique, France) was added to the cultures. Cells were harvested 8 hours later and 'H-thymidine incorporation measured by standard scintillation techniques. Proliferation was considered positive when 'H-thymidine incorporation was superior to two standard deviations above the mean of cultures containing lo5 irradiated B lymphocytes with medium alone (or 1,322 cpm). The influence of irradiated B cells (B*) was evaluated by the ratio of T-lymphocyte proliferation in the presence of B* to T-lymphocyte proliferation alone ([B* + T]/T).
The effect of the B-cell clone was statistically signficiant (Student's t test) for a ratio inferior to 0.7 or superior to 1.3.
Statistical Analysis
A data correlation study was performed using three statistical tests: Student's t test, corrected x2 test, and Mann and Whitney U test.
Computation of Patient Survival
and comparison of the groups was performed according to Byar." Actuarial survival was estimated according to Schwartz et al, 29 
RESULTS
Analysis of Activation Features in T Lymphocytes Isolated From NHL Lymph Nodes
In this study we used CD25 and OKT9 MoAbs, respectively, directed against IL-2 and transferrin membrane receptors, as indicators of T-cell
In most of the cases the number of positive cells was low: more than 10% (10% to 20%) of positive TIL-T were observed in only 12% of invaded lymph nodes (4 of 34 cases). In healthy donors' blood and in lymph nodes with benign hyperplasia it never exceeded 10%. With the OKT9 MoAb, more than 20% (20% to 63%) of positive TIL-T were observed in 24% of invaded lymph nodes (8 of 34 cases) while they were less than 15% in all the control specimens (Tables  2 and 3 ).
T Lymphocytes isolated from the different samples (blood or lymph node, N H L or control) were cultured for 6 days with or without rIL-2.
Whatever their origin, no spontaneous proliferation was ever demonstrated. With rIL-2, there was a response in the majority of cases: 80% of lymph nodes invaded by N H L or with reaction hyperplasia and 100% of healthy donor peripheral blood (nonsignificant difference). When the response was present, the intensity was extremely variable, particularly TIL-T in NHL, with values oscillating between 1,464 to 39,399 cpm. Although heterogeneity appeared to be more restrained in the control samples, the smallest number of events should be taken into consideration (Tables 2 and 3) .
Phenotype of the rIL-2 Responding TIL
Whenever the number of recovered cells was sufficient (seven cases), we analyzed CD3 CD4 and CD8 expression on TIL after a 6-day culture with rIL-2 (40 U/mL). Table 4 shows that CD3+ cells were always greater than 90%, demonstrating mainly the proliferation of T lymphocytes.
Influence of the B-Cell Clone on Autologous T-Lymphocyte Proliferation in the Presence of rIL-2
We compared the response to rIL-2 of TIL-T alone or in the presence of the irradiated malignant B cells added in a 1:l ratio. Their influence was taken into consideration ( P < .05) for a variation in TIL-T proliferation of at least f 30% ([B* + TI /T < 0.7 or > 1.3). According to this criteria, three groups among the 39 N H L were isolated ( Table 2) .
The B-cell clone had no effect on TIL-T proliferation (15 cases or 38%). In five cases (33%) TIL-T alone did not respond to rIL-2, and in 10 cases (67%) it proliferated with values from 1,464 to 39,399 cpm. In four cases, experiments were performed with an increased number of stimulating B lymphocytes (2 x lo5 cells/well instead of lo5). In three cases, TIL-T response to rIL-2 remained the same while in one case it was increased ( x 2).
The B-cell clone enhanced rIL-2 TIL-T response (16 cases or 41%). This effect was variable from one lymph node to another with a (B* + T)/T ratio ranging from 1.7 to 17.6. In 19% of the cases, TIL-T alone did not respond to rIL-2, and in 81% of them it proliferated with values ranging from 1,464 to 9,202 cpm.
Surface markers of activation.
T-lymphocyte response to rIL-2.
-Group 0.
-Group +. correlation between these groups and CD4lCD8 or with activation markers on TIL-T; a and b (5 or 17) represent samples from the same patient.
-Group -. The B-cell clone produced a decrease in TIL-T proliferation in the presence of rIL-2 (eight cases or 21%). This effect varied in proportion from 0.3 to 0.7. In all cases, T lymphocytes alone also responded to rIL-2 (range 1,656 to 9,737 cpm). Two patients (cases 5 and 17) sampled on two different occasions remained within the same group at the time of diagnosis and during relapse.
In healthy donors' blood and hyperplastic lymph nodes (Table 3) 
Correlation With Clinical Presentation and Outcome
Patients had been classified into four clinicopathologic stages2' and their survival evaluated with the actuarial
Results showed no difference with the first classification but a better survival in group + and 0 than in group -(statistically significant [P < .05] between group + and -) ( Table 1 and Fig 1) . Table 5 shows the effect of the B-cell clone according to its immunologic phenotype. There was no relationship with the pan B markers (CD19, CD20, CD24). Differences appeared with the B-cell subset restricted antibodies: CDlO and CD21 were 4 times more frequent in groups + and 0 than in group -, and CD5 about 5 to 3 times more frequent in group 0 than in groups + and -. However, these differences are not statistically significant ( P > .05). The heavy and light chain Ig isotypes on the B-cell clone surface are shown in Table 1 . There is no relationship with the influence of the malignant population. Table 1 shows the distribution of lymphomas in each of the three groups previously defined. There is no evident correlation with their more or less differentiated features. However, the particular distribution of centrofollicular N H L should be noted ( Working formulation classification. Disease prognosis according to the influence of the B-cell clone on TIL-T proliferation is shown in Table 7 . N H L of group + are essentially low-grade malignancies (75%) while those of group -are intermediate-grade malignancies (88%). Differences are statistically significant ( P < .02). Group 0 is divided almost evenly between the low-grade malignancies (60%) and the intermediate-grade malignancies (40%), and it is not statistically different from either group + or group Grenoble cytologic classification. Eighty-eight percent of the group + and 87% of the group 0 N H L belong to cytologic class 1, whereas the group -N H L appears to be strongly linked to class 3 (88%) ( Table 7 ). The distributions in classes 1 and 3 are significantly different between groups + and -but also between groups 0 and -(P < .Ol), in contrast with the results of the WF. We show that the Grenoble classification gives the best degree of correlation with that kind of malignant B-cell clone influence. This results essentially from the classification of diffuse centrofollicular lymphomas for which the cytology is more discriminative than the histology. 
Correlation With Different NHL Classifications
Percentage of the TIL-T
TIL-T were identified in lymph nodes by two MoAbs, CD3 and CD5. The relative proportions of malignant B cells and T lymphocytes appeared to be highly variable from one patient to another with T-lymphocyte values ranging from 5% to 80%. In group + there are more than 35% TIL-T in 88% of the cases (mean 44% 2 17%), while in group -, there are less than 26% in 75% of the cases (mean 24% f 15). In group 0, the number of T lymphocytes is greater than 35% in 40% of the cases, and inferior to 26% in 60% of the cases (mean 31% 18%). Differences are significant between groups + and -( P < .05), but not between groups + and 0.
DISCUSSION
In lymph nodes invaded by malignant lymphoma, the B-cell clone is always associated in highly variable proportions, most likely with normal T lymphocytes. We explored the significance of these TIL-T in the tumor microenvironment by looking for evidence in favor of their reactivity toward the malignant cells.
First, we tried to demonstrate the existence of activated TIL-T by studying the presence of IL-2 and transferrin surface receptor^^^*^^ on one hand, and the proliferative response to rJL-2 on the other. Only activated T lymphocytes proliferate at low concentrations of rIL-2.24 CD25 and OKT9 + TIL-T are present in 90% of the cases, but their percentage is very low in most samples. Results are similar when IL-2 receptors are studied on histologic slide^.'^*^^.'^ In 80% of the NHL studied, TIL-T respond to IL-2, but with a great variability from one patient to another. This inconsistency has also been observed in solid tumor^.^.'^ Cell-cycle analysis also confirms the existence of normal proliferating TIL-T in human lymphomas and demonstrates that this fraction is larger than in reactive lymph nodes." Our results show that there is no unique behavior within NHL, and no significant difference in comparison with control populations. However, other studies performed in the same patients showed greater T-lymphocyte activation in the tumor than in the peripheral blood . 2 Secondly, we looked for relationships between TIL-T and malignant B cells. In MLTC there was no proliferation of TIL-T (data not shown). However, in the presence of rIL-2 we demonstrated functional interrelations between B and T cells: the B-cell clone increased the response to rIL-2 in 41% Table 6 . Percent of Nodular, Nodular and Diffuse, and Diffuse Centrofollicular NHL in Groups +, 0, and - 
6-cell clone was studied with six MoAbs, specific either for pan B-cell population (CD19, CD20, CD24) or for 6-cell subsets (CD21, CD5, CD 10). Statistical analysis showed no correlation between 6-cell phenotype and the kind of influence (+, 0, -1 on TIL-T proliferation with rlL-2. 
The nodular or diffuse characteristics of the malignant proliferation was studied in centrofollicular lymphomas. In group +, 6-cell proliferation was essentially N or ND (87%); in group 0 it was either N, ND (55%) or D (45%); whereas it was always D (100%) in group -.
Abbreviations: N, nodular; D, diffuse; ND, nodular and diffuse. *Number of cases studied is in parentheses. E-cell influence on TIL-T proliferation was compared with two classifications that have an essentially prognostic value: the Working Formulation (WF) (top) and the Grenoble cytological classification (GCC) (bottom). The majority of group + NHL were classified in the categories of the lowest malignancy, whereas group -NHL were of higher malig nancy. The degree of malignancy in group 0 was not the same whether it was evaluated with one classification or the other. With the WF, NHL were almost equally low-grade and intermediate-grade malignancies while they were essentially in class 1 of favorable prognosis with the GCC.
of the cases, inhibited it in 21% of the cases, and was without effect in 34%.
The mechanism of the positive interaction has not been addressed in this work, but it is under investigation. Several hypotheses may explain this T-cell activation: (1) a simple feeder effect; (2) cell-membrane contact, either nonspecific such as HLA class I1 recognition (as in AMLR6), or specific such as Ig idiotype recognition; (3) it may also be mediated by soluble factors such as 11-1,32 which is known to be The originality of N H L lymph nodes as compared with control populations is the existence of a group within which B cells provide an inhibiting effect on T-cell proliferation. In our observations, we can rule out the hypothesis of rIL-2 fixation on B lymphocytes (which would make it unavailable for T lymphocytes). This phenomenon has been described in CLL37 but seems improbable in the majority of our observations because, in 7 of 9 cases, the B lymphocytes were not positive for CD25 antibodies, and in 8 of 9 cases did not proliferate in the presence of rIL-2. Furthermore, we were able to demonstrate, in one patient, that an increase in rIL-2 concentration (80 U/mL) had no influence on the negative effect of the B-cell clone (data not shown). The significance of these different effects in the pathophysiology of lymphoma remains to be defined. In our study we investigated the existence of relationships between three kinds of B-cell clone influence (stimulating, inhibiting, or null) and disease expression.
Our results show that a correlation exists between the high percentage of TIL-T in vivo and evidence of stimulation by the malignant clone in vitro, and inversely between the weak proportion of TIL-T in vivo and the absence or inhibition of their proliferation in vitro (P < .05).
Because B-cell lymphomas represent the expansion of B-cell clones arrested in extremely varied stages of maturation, we wondered whether the nature of the B-cell clone (its differentiation level) was related to the effects observed. The response provided by statistical analysis is negative. However, differences appeared in the distribution of the three B-cell subset restricted antigens: CD5, CD10, and CD21. This suggests that by increasing the number of samples one could isolate phenotypic groups linked to a B-cell clone effect. The malignant cell differentiation as determined by the Kiel classification does not show a correlation with the stimulating, inhibiting, or null effect of the clone on T-lymphocyte proliferation. However, nodular proliferations appear to be linked to groups + and 0, while diffuse proliferation to group -.
The observation of a relationship between the results of MLTC and the disease prognosis in solid led us to examine this situation in our study. There was no correlation with prognosis as evaluated by clinicopathologic classification, but correlations appeared with other parameters. Two classifications have an exclusively prognostic objective for NHL: the WF,27 which is the reference classification, and the Grenoble cytologic classification.28 Thus we show that the positive influence of the clone is associated with a favorable prognosis in 75% (WF) or 88% (Grenoble classification) of the cases. Conversely, the inhibiting influence of the clone is linked to a poor prognosis in 88% of the cases ( W F and Grenoble classifications). The prognosis for group 0 is different according to whether it is evaluated with the W F (60% of low-grade malignancies and 40% of intermediategrade malignancies) or with the Grenoble classification (87% of favorable prognosis and 13% of poor prognosis). The difference, as we have already shown, comes from the distribution of some diffuse centrofollicular lymphomas in cytologic class 1 and of favorable prognosis. To confirm the prognostic values of the groups +, 0, and -, a statistical comparison of the patients survival was made. A better prognosis was effectively shown for groups + and 0, and differences were significant between groups + and -(P < .OS). This difference in the disease prognosis is not due to an intrinsic T-cell deficiency, as the response to rIL-2 or mitogens is not statistically different between the three groups. These results are in agreement with those obtained from solid tumors, showing positive MLTC in patients without metastases, negative in those with positive MLTC in favorable evolutions, and negative in the pejorative
The existence of a correlation between TIL-T response to rIL-2 in the presence of malignant autologous B cells and the disease expression led us to postulate that these reactive TIL-T might be important in the pathophysiology of the disease. Recent studies on solid tumors suggest that these cells might have some therapeutic application in the future if, as it was s h o~n ;~.~~ tumorspecific cytotoxic activity could be developed from them.
